Vitiligo patients can benefit from any number of therapies offered by dermatologists. One expert discusses the etiologies of this hypopigmentary disorder, its various treatments and its therapeutic challenges.
Emerging Therapeutic for Non-Segmental Vitiligo: Merck’s MK-6194
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Study Highlights Efficacy of Lotion with Biotechnological Phytocomplex, Niacinamide, and Succinic Acid in Enhancing Microbiota Diversity and Reducing Acne Severity
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Electroablation Plus Pharmacotherapy Leads to Reduction in Keloid Volume
Expert Reflections: Impact of Dermatology Times